Regenerative Medicine Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC337

Regenerative medicines have the capability to replace, repair, and regenerate organs and tissues affected owing to disease, natural ageing process or injury. These regenerative medicines are able to restore the functionality of tissues and cells and are applicable in a broad range of degenerative diseases such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers are emphasizing on developing technologies based on gene, biologics, somatic and stem cells. Stem cells are capable of differentiation and proliferation due to which they are of significance in this field. Presently, majority of treatments accessible for life-threatening diseases or degenerative do not provide a cure or are palliative; however, these have the ability to regenerate or replace the organ and tissues suffering from injury or disorder.

The factors driving the market growth for regenerative medicine are technological developments in organ and tissue regeneration, increasing incidences of chronic disorders and trauma emergencies, noticeable potential of nanotechnology, and growing popularity of stem cell technology. Furthermore, increasing prevalence of degenerative disorders and scarcity of organs for transplantation are anticipated to fuel the growth of this market. The noticeable potential of regenerative medicine to repair, replace, and regenerate damaged organs and tissues has fueled the market growth. Moreover, use of nanomaterials in drug delivery, wound care, and immunomodulation has opened growth paths for the regenerative medicines market. However, strict regulatory hurdles and high cost of treatment are expected to hamper the market growth.

The global regenerative medicine market, based on materials, is bifurcated into three wide categories, namely, biologically derived materials, synthetic materials, and genetically engineered materials. The demand for biological and injury, or derived materials is more in the market owing to the presence of notable characteristics such as higher immune response and cellular adoption. Regenerative medicine and tissue engineering are usually used in the biomedical area for repair and regeneration of trauma tissues or deceased tissue. Tissue regeneration can be conducted both in vivo and vitro conditions. Tissue engineering needs artificial medium for regeneration of tissues. This artificial medium helps in differentiation and proliferation of cells, leading to regeneration of tissues. The adoption of synthetic tissue engineering materials is presently high owing as it offers improved competence in comparison to other naturally derived materials.

In term of geography, the market for the global regenerative medicine is bifurcated into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA). North America is the most prominent region in the worldwide regenerative medicines industry and is anticipated to be the most preferred for new entrants due to the presence of large number of applications in the region. The regenerative medicines market in North America is in its mounting phase and is anticipated to show high potential during the forecast period, as maximum remedies are in the 3rd phase of clinical trials. This shows the involvement of firms for commercialization of regenerative medicine products. Promising regulatory and reimbursement guidelines for tissue engineering displays interest of government establishments fulfilling the mounting need of regenerative products. However, strict regulatory guidelines relating to stem cell technologies have created major challenges for the acceptance of embryonic stem cells, due to moral issues and controversies about its source; thus, hampering the market growth. Consumer awareness about the benefits of regenerative medicine has escalated in the recent years, which has increased the demand. Followed by North America, Europe is the most attractive market for new entrants in the global regenerative medicine market. Asia-Pacific is anticipated to be the fastest growing region.

Prominent players in the market are investing large sum in research and development activities to develop superior products, in order to cater to the current demand. Some of the key players in the global regenerative medicines market are Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic plc, Organogenesis, Inc. (Advanced Biohealing), Baxter International, Inc., DePuySynthes, Acelity Holdings, Inc., Integra Lifesciences Holdings Corporation, Ocata Therapeutics, Inc. (Astellas Pharma, Inc.), CryoLife, Inc. among others.

Market Segmentation

Market by Material

·         Biologically derived materials

·         Synthetic materials

·         Genetically engineered materials

Market by Application

·         Cardiovascular

·         Oncology

·         Dermatology

·         Musculoskeletal

·         Wound Healing

·         Ophthalmology

·         Neurology

·         Others

Market by Technology

·         Tissue Engineering

·         Gene Therapy

·         Cell Therapy

·         Small Molecules & Biologics

Market by Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Philippines

o   Rest of Asia-Pacific

·         Latin America

o    Brazil

o   Chile

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro

Ambulatory Health Care Services Market By Type (Primary Care Offices, Medical Specialty, Emergency Departments, Surgical Specialty), By Application (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie

Ambulatory EHR Market By Application (Patient Management, Practice Management, E-prescribing, Population Health Management, Referral Management, Health Analytics, Decision Support), By Delivery Mode (Client Server-based, Web-based), By End User Mode (Independent Ambulatory Centers, Hospital-owned Ambulatory Centers) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Healthcare Consulting Services Market By Type of Service (IT Consulting, Digital consulting, Financial Consulting, Operation Consulting, Strategy Consulting, HR & Talent Consulting), By End User (Life Science Companies, Hospitals, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta

Cart Summary